X0306 4/A 2014-06-17 2014-06-18 1 0001470915 Pharmagen, Inc. PHRX 0001607428 Perry Stephen M. 9337 FRASER AVENUE SILVER SPRING MD 20910 0 0 0 1 Former Director Common Stock 2014-06-17 4 J 0 11100000 D 0 I By Kymanox, LLC The transaction reported on the original Form 4, filed with the Securities and Exchange Commission on June 18, 2014, was never consummated. As a result, the reporting person never acquired beneficial ownership over the shares identified in the original Form 4. Kymanox, LLC, an Illinois limited liability company, was to be the registered owner of the shares identified in the original Form 4 filed with the Securities and Exchange Commission on June 18, 2014. As indicated in the previous footnote, the consummation of the transaction pursuant to which Kymanox was to acquire the shares identified in the original Form 4 was never consummated. The reporting person, Stephen Perry, is the President and Chief Executive Officer of Kymanox, LLC. Because the transaction identified in the original Form 4 was never consummated, the reporting person never acquired beneficial ownership over the shares identified therein. This Form 4/A is being resubmitted because the previous version inadvertently failed to indicate that the reporting person is no longer subject to Section 16. /s/ Stephen Perry 2014-07-08